These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
536 related articles for article (PubMed ID: 29726297)
1. Glioma targeting peptide modified apoferritin nanocage. Zhai M; Wang Y; Zhang L; Liang M; Fu S; Cui L; Yang M; Gong W; Li Z; Yu L; Xie X; Yang C; Yang Y; Gao C Drug Deliv; 2018 Nov; 25(1):1013-1024. PubMed ID: 29726297 [TBL] [Abstract][Full Text] [Related]
2. Apoferritin Nanocage for Brain Targeted Doxorubicin Delivery. Chen Z; Zhai M; Xie X; Zhang Y; Ma S; Li Z; Yu F; Zhao B; Zhang M; Yang Y; Mei X Mol Pharm; 2017 Sep; 14(9):3087-3097. PubMed ID: 28728419 [TBL] [Abstract][Full Text] [Related]
3. Enhanced blood-brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles. Liang M; Gao C; Wang Y; Gong W; Fu S; Cui L; Zhou Z; Chu X; Zhang Y; Liu Q; Zhao X; Zhao B; Yang M; Li Z; Yang C; Xie X; Yang Y; Gao C Drug Deliv; 2018 Nov; 25(1):1652-1663. PubMed ID: 30394123 [TBL] [Abstract][Full Text] [Related]
4. Dual-modified natural high density lipoprotein particles for systemic glioma-targeting drug delivery. Cui L; Wang Y; Liang M; Chu X; Fu S; Gao C; Liu Q; Gong W; Yang M; Li Z; Yu L; Yang C; Su Z; Xie X; Yang Y; Gao C Drug Deliv; 2018 Nov; 25(1):1865-1876. PubMed ID: 30474437 [TBL] [Abstract][Full Text] [Related]
5. Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma. Fu S; Liang M; Wang Y; Cui L; Gao C; Chu X; Liu Q; Feng Y; Gong W; Yang M; Li Z; Yang C; Xie X; Yang Y; Gao C ACS Appl Mater Interfaces; 2019 Jan; 11(2):1841-1854. PubMed ID: 30582685 [TBL] [Abstract][Full Text] [Related]
6. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands. Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462 [TBL] [Abstract][Full Text] [Related]
7. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth. Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853 [TBL] [Abstract][Full Text] [Related]
8. Co-administration of dual-targeting nanoparticles with penetration enhancement peptide for antiglioblastoma therapy. Miao D; Jiang M; Liu Z; Gu G; Hu Q; Kang T; Song Q; Yao L; Li W; Gao X; Sun M; Chen J Mol Pharm; 2014 Jan; 11(1):90-101. PubMed ID: 24295590 [TBL] [Abstract][Full Text] [Related]
9. Angiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting delivery. Gao H; Zhang S; Cao S; Yang Z; Pang Z; Jiang X Mol Pharm; 2014 Aug; 11(8):2755-63. PubMed ID: 24983928 [TBL] [Abstract][Full Text] [Related]
10. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma. Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043 [TBL] [Abstract][Full Text] [Related]
11. Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery. Chen Y; Zhang M; Jin H; Li D; Xu F; Wu A; Wang J; Huang Y Theranostics; 2017; 7(14):3489-3503. PubMed ID: 28912890 [TBL] [Abstract][Full Text] [Related]
12. Dual Functional Peptide-Driven Nanoparticles for Highly Efficient Glioma-Targeting and Drug Codelivery. Kuang Y; Jiang X; Zhang Y; Lu Y; Ma H; Guo Y; Zhang Y; An S; Li J; Liu L; Wu Y; Liang J; Jiang C Mol Pharm; 2016 May; 13(5):1599-607. PubMed ID: 27058780 [TBL] [Abstract][Full Text] [Related]
13. Enhanced BBB and BBTB penetration and improved anti-glioma behavior of Bortezomib through dual-targeting nanostructured lipid carriers. Farshbaf M; Mojarad-Jabali S; Hemmati S; Khosroushahi AY; Motasadizadeh H; Zarebkohan A; Valizadeh H J Control Release; 2022 May; 345():371-384. PubMed ID: 35301054 [TBL] [Abstract][Full Text] [Related]
14. Liposome-Based Systemic Glioma-Targeted Drug Delivery Enabled by All-d Peptides. Ying M; Zhan C; Wang S; Yao B; Hu X; Song X; Zhang M; Wei X; Xiong Y; Lu W ACS Appl Mater Interfaces; 2016 Nov; 8(44):29977-29985. PubMed ID: 27797175 [TBL] [Abstract][Full Text] [Related]
15. A novel peptide ligand RAP12 of LRP1 for glioma targeted drug delivery. Ruan H; Chai Z; Shen Q; Chen X; Su B; Xie C; Zhan C; Yao S; Wang H; Zhang M; Ying M; Lu W J Control Release; 2018 Jun; 279():306-315. PubMed ID: 29679668 [TBL] [Abstract][Full Text] [Related]
16. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery. Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902 [TBL] [Abstract][Full Text] [Related]
17. Blood-Brain Barrier- and Blood-Brain Tumor Barrier-Penetrating Peptide-Derived Targeted Therapeutics for Glioma and Malignant Tumor Brain Metastases. Chen L; Zeng D; Xu N; Li C; Zhang W; Zhu X; Gao Y; Chen PR; Lin J ACS Appl Mater Interfaces; 2019 Nov; 11(45):41889-41897. PubMed ID: 31615203 [TBL] [Abstract][Full Text] [Related]
18. Glioma-Targeted Drug Delivery Enabled by a Multifunctional Peptide. Zhang M; Chen X; Ying M; Gao J; Zhan C; Lu W Bioconjug Chem; 2017 Mar; 28(3):775-781. PubMed ID: 27966896 [TBL] [Abstract][Full Text] [Related]
19. Pep-1&borneol-Bifunctionalized Carmustine-Loaded Micelles Enhance Anti-Glioma Efficacy Through Tumor-Targeting and BBB-Penetrating. Guo X; Wu G; Wang H; Chen L J Pharm Sci; 2019 May; 108(5):1726-1735. PubMed ID: 30537472 [TBL] [Abstract][Full Text] [Related]
20. Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB. Chen C; Duan Z; Yuan Y; Li R; Pang L; Liang J; Xu X; Wang J ACS Appl Mater Interfaces; 2017 Feb; 9(7):5864-5873. PubMed ID: 28128553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]